IGM Biosciences is a clinical-stage biotechnology company focused on developing engineered IgM antibodies for the treatment of autoimmune and inflammatory diseases
IGM Biosciences is a clinical-stage biotechnology company focused on developing engineered IgM antibodies for the treatment of autoimmune and inflammatory diseases. The company leverages its proprietary platform to create therapeutic IgM antibodies that offer novel treatment options.